Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider (Q36339698)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider |
scientific article |
Statements
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer (English)
Eleftherios P Mamounas
Edward H Romond
Priya Rastogi
Charles E Geyer
Michael S Ewer
Vikas Rathi
Louis Fehrenbacher
Adam Brufsky
Catherine A Azar
Patrick J Flynn
John L Zapas
Jonathan Polikoff
Howard M Gross
David D Biggs
James N Atkins
Elizabeth Tan-Chiu
Ping Zheng
Norman Wolmark
17 September 2012
1 reference
1 reference
1 reference
1 reference
1 reference